Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001185185-21-000254
Filing Date
2021-02-22
Accepted
2021-02-19 19:50:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A dangdai20210219_sc13da.htm SC 13D/A 49633
  Complete submission text file 0001185185-21-000254.txt   51445
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 (301) 825 5320
Cellular Biomedicine Group, Inc. (Subject) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82437 | Film No.: 21657876
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 369 LUMO ROAD HONGSHAN DISTRICT WUHAN, HUBEI F4 430070
Business Address 369 LUMO ROAD HONGSHAN DISTRICT WUHAN, HUBEI F4 430070 86-027-87596552
Dangdai International Group Co. Ltd (Filed by) CIK: 0001678024 (see all company filings)

EIN.: 000000000 | State of Incorp.: K3 | Fiscal Year End: 1231
Type: SC 13D/A